4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-079229
Director sold 7,500 shares at an average $104.45 ($783,375)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2025-05-27 | Sale 10b5-1 | −3,750 | $105.47 | $395,513 | 50,387 | D |
| Coleman Mark Director | 2025-05-28 | Sale 10b5-1 | −3,750 | $103.43 | $387,863 | 46,637 | D |
| Open-market sales · 7,500 sh · avg $104.45 · $783,375 | |||||||
Loading xslF345X05/ownership.xml…